Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2020-10-01 2020-09-21
Drug Identification Number 02250306 02250306
Brand name CEFTRIAXONE SODIUM FOR INJECTION BP CEFTRIAXONE SODIUM FOR INJECTION BP
Common or Proper name Ceftriaxone Sodium for Injection, BP Ceftriaxone Sodium for Injection, BP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients CEFTRIAXONE CEFTRIAXONE
Strength(s) 2G 2G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 x 2g vial 10 x 2g vial
ATC code J01DD J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-30 2020-09-30
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments
Health Canada comments